Phase 2 Dose-ranging Study of SEL-212 in Symptomatic Gout Patients: Selection of Doses for Further Clinical DevelopmentRehan Azeem,Alan Kivitz,Horacio Plotkin,Lloyd Johnston,Takashi K. Kishimoto,Justin Park, Stephen Smolinski,Wesley DeHaanARTHRITIS & RHEUMATOLOGY(2019)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要